RavenQuest BioMed(OTC) RVVQF

Market CapN/A

Since IPO (2018)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

RavenQuest BioMed last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-05-26

RavenQuest BioMed stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-92.31%	USD 0.00	2026-05-14
1 month	+0%	USD 0.00	2026-04-24
3 month	+0%	USD 0.00	2026-02-25
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-05-23
3 year	+0%	USD 0.00	2023-05-23
5 year	-99.99%	USD 0.01	2021-05-27
Since inception	-100%	USD 1.03	2018-03-05

RavenQuest BioMed Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$1.52M

Net Income (TTM)

-CA$32.35M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-15.52 (Low)

Dividend

$0.00

Beta (Volatility)

-15.52 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 3, 2025

Dividend

$0.00

Beta (Volatility)

-15.52 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 3, 2025

RVVQF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RavenQuest BioMed

RavenQuest BioMed Inc. operates within the cannabis industry, focusing on the cultivation of cannabis and providing management and consulting solutions. The company is structured into two main divisions: consulting and the growth and sale of medical cannabis, with products marketed under the Lore Cannabis and Bloomera brands.

Products and Services

Cultivation of high-quality cannabis for medical use
Management and consulting solutions for cannabis operations
Research and development in cannabis-related technologies

Growth Outlook

Expansion into new markets is anticipated as cannabis regulations evolve
Increased demand for medical cannabis products is projected
Strategic partnerships may enhance operational capabilities and market reach

Financial Highlights

Recent quarterly revenue of 709,642 CAD shows growth potential
Gross profit margin of 62.4% indicates strong product demand
Current ratio of 1.14 suggests adequate short-term financial health

RavenQuest BioMed Inc. has positioned itself as a key player in the cannabis sector, leveraging its expertise in cultivation and consulting. The company's focus on medical cannabis aligns with growing consumer demand and evolving regulations, presenting significant growth opportunities. Recent financial performance indicates a positive trajectory, with a notable gross profit margin that reflects effective operational management. The current ratio further underscores the company's ability to meet short-term obligations, enhancing its appeal to potential investors. As the cannabis market continues to expand, RavenQuest BioMed Inc. is well-positioned to capitalize on emerging opportunities.

AI Generated • Aug 30, 2026

Industry

Professional Services

Sector

Industrials

Headquarters

Vancouver, BC V6E 2K3, CA

RVVQF Financials

Key Financial Metrics (TTM)

Gross Margin

63.75%

Operating Margin

-1366.43%

Net Income Margin

-2423.87%

Return on Equity

-203.42%

Return on Capital

-48.18%

Return on Assets

-80.81%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

1.00K

Avg. Volume

Financials (TTM)

Gross Profit

-CA$37.18K

Operating Income

-CA$17.75M

EBITDA

-CA$25.86M

Operating Cash Flow

-CA$934.83K

Capital Expenditure

-CA$7.17M

Free Cash Flow

-CA$8.11M

Cash & ST Invst.

CA$749.14K

Total Debt

CA$14.78M

RavenQuest BioMed Performance Analysis

RavenQuest BioMed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2018-10-31	-182.0%
Q1	2019-01-31	312.8%
Q2	2019-04-30	117.7%
Q3	2019-07-31	8.6%

RavenQuest BioMed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2018-10-31	-534.4%
Q1	2019-01-31	86.5%
Q2	2019-04-30	1.8%
Q3	2019-07-31	6.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2019YOY CHG

Revenue

CA$709.64K

+312.9%

Gross Profit

CA$442.82K

+182.1%

Gross Margin

62.40%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$3.12M

+1.9%

EBITDA

-CA$1.42M

+41.8%

Quarterly Fundamentals

Name

Q3 2019YOY CHG

Total Cash

CA$749.14K

-45.0%

Total Debt

CA$14.78M

+18.0%

Accounts Receivable

CA$915.30K

-40.2%

Inventory

CA$271.26K

N/A

Long Term Debt

CA$13.32M

+6.3%

Short Term Debt

CA$1.46M

N/A

Return on Assets

-80.81%

N/A

Return on Invested Capital

-48.18%

N/A

Free Cash Flow

-CA$2.09M

+82.1%

Operating Cash Flow

-CA$1.44M

+77.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

THCBFTHC Biomed Intl Ltd.

THCBFTHC Biomed Intl Ltd.$0.00+0.00%

AVTBFAvant Brands Inc.

AVTBFAvant Brands Inc.$0.49+9.26%

CANNTrees Corporation

CANNTrees Corporation$0.02+22.36%

BBRRFBlueberries Medical Corp.

BBRRFBlueberries Medical Corp.$0.01+12.88%

CPIVFCaptiva Verde Wellness Corp.

CPIVFCaptiva Verde Wellness Corp.$0.04-14.00%

PCLOFPharmaCielo Ltd.

PCLOFPharmaCielo Ltd.$0.04+7.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.15-0.12%

NVDANvidia

NVDANvidia$230.36+0.01%

PATHUiPath

PATHUiPath$15.19-0.17%

INTCIntel

INTCIntel$95.80+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.13+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.74-0.02%

TSLATesla

TSLATesla$354.08-0.06%

Questions About RVVQF

What is the current price of RavenQuest BioMed?

RavenQuest BioMed is trading at $0.00 per share.

What is the 52-week range for RavenQuest BioMed?

Over the past 52 weeks, RavenQuest BioMed has traded between $0.00 and $0.00.

How much debt does RavenQuest BioMed have?

RavenQuest BioMed total debt is unavailable.

How much cash does RavenQuest BioMed have on hand?

RavenQuest BioMed does not have cash on hand data available.

What is RavenQuest BioMed’s dividend yield?

RavenQuest BioMed does not currently have a dividend yield.

RavenQuest BioMed(OTC) RVVQF

RavenQuest BioMed Financials at a Glance

RVVQF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About RavenQuest BioMed

RVVQF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

RavenQuest BioMed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RVVQF

What is the current price of RavenQuest BioMed?

What is the 52-week range for RavenQuest BioMed?

How much debt does RavenQuest BioMed have?

How much cash does RavenQuest BioMed have on hand?

What is RavenQuest BioMed’s dividend yield?

Premium Investing Services